Amanita muscaria
Amanita muscaria (fly agaric) is the iconic red-and-white-spotted mushroom, psychoactive through muscimol and ibotenic acid — NOT psilocybin. Its effects are sedative and dream-like (acting on GABA-A receptors, closer to alcohol or a sedative than a classic psychedelic). It is federally unscheduled and legal in the US except Louisiana, but it is genuinely toxic and the commercial product market is riddled with contamination and mislabeling.
Overview
Amanita muscaria, commonly called fly agaric, is the archetypal red-capped, white-spotted 'toadstool' of fairy tales and video games. Unlike 'magic mushrooms', its psychoactivity comes from muscimol and ibotenic acid, not psilocybin — a distinction that matters chemically, experientially, and legally. It has thousands of years of ritual use, and since roughly 2022 has fueled a large commercial market of gummies and extracts sold as a legal, psychoactive botanical. It is also genuinely poisonous if prepared or dosed carelessly.
Source: peer-reviewed literature (NIH/PMC); FDA; Wikipedia (CC-BY-SA)
Chemistry & mechanism of action
Amanita muscaria's main active compounds are ibotenic acid and muscimol. Ibotenic acid is a glutamate-receptor agonist and is largely converted (by drying or in the body) to muscimol, which is the primary agent of the experience. Muscimol is a potent agonist at GABA-A receptors — the brain's main inhibitory system, the same broad target as alcohol, benzodiazepines, and sleep aids. This is why the effect is sedative, dream-like, and dissociative rather than the serotonergic (5-HT2A) visual psychedelia of psilocybin.
Source: peer-reviewed literature (NIH/PMC); Wikipedia (CC-BY-SA)
Effects
Reported effects are sedative and 'oneiric' (dream-inducing): relaxation, altered perception, dreamy or delirious states, and sometimes euphoria, quite different from the visual, ego-dissolving character of psilocybin. Onset and intensity are unpredictable and vary with preparation and individual sensitivity. Unpleasant physical effects are common, especially nausea, vomiting, sweating, muscle twitching, and — with ibotenic acid — a delirium that can alternate between excitation and heavy sedation.
Source: peer-reviewed literature (NIH/PMC); Wikipedia (CC-BY-SA)
Risks & harms
Amanita muscaria is genuinely toxic, and its risks are frequently understated by the 'legal mushroom' marketing around it. Ibotenic acid is a neurotoxin, and raw or poorly prepared mushrooms can cause a distressing toxidrome: nausea, vomiting, profuse sweating, confusion, agitation alternating with deep sedation, muscle twitching, and in serious cases seizures and coma. Effects are unpredictable because muscimol/ibotenic content varies enormously between mushrooms and preparations, and a dangerous look-alike, Amanita pantherina, is markedly more potent. The commercial product market is a major hazard: independent and FDA testing of 'mushroom gummies' has repeatedly found undisclosed and dangerous ingredients — including psilocybin analogs, prescription drugs, and other research chemicals (the Diamond Shruumz outbreak caused dozens of hospitalizations and several deaths). Products may be mislabeled as to species or contents entirely. Combining muscimol with alcohol or other CNS depressants deepens sedation. Because it acts on GABA-A, it should not be treated like a gentle psychedelic. Anyone with a seizure, prolonged vomiting, severe confusion, or unresponsiveness needs emergency care — call 911, and Poison Control at 1-800-222-1222 can advise. This page has not yet been medically reviewed.
Source: peer-reviewed literature (NIH/PMC); FDA; SAMHSA
Legal status (US)
In the United States, Amanita muscaria and its compounds muscimol and ibotenic acid are NOT federally scheduled controlled substances — unlike psilocybin (Schedule I), these compounds are not on the federal controlled-substances list, which is why the mushroom is sold commercially. It is legal to buy, possess, and consume in 49 states; the one exception is Louisiana, which bans it for human consumption under a long-standing hallucinogenic-plants law (Act 159 of 2005). The FDA determined that Amanita muscaria, its extracts, and its constituents muscimol, ibotenic acid, and muscarine are unapproved food additives for use in conventional food (a Dec 2024 Letter to Industry), which affects gummies and edibles but did not ban possession or schedule the compounds; enforcement is selective. Some states have considered restrictions (a 2025 Texas attempt failed). This is an evolving area; verify current federal and state law before relying on any status. This page has not yet been medically reviewed.
Source: DEA; FDA; Louisiana Act 159 (2005); US federal + state law
Drug laws and enforcement change and vary by country. This is not legal advice. Always confirm with the destination’s embassy or official drug authority before traveling — penalties can be severe, including imprisonment.
Before you travel
Verify current rules with the destination country’s official drug authorityand your own country’s embassy before traveling. Find the destination’s U.S. embassy & official country guidance →
Non-U.S. travelers: check your own government’s travel advisory and embassy.
If you’re detained or arrested abroad
Contact your own country’s embassy or consulatein the destination immediately — notthe destination’s authorities. U.S. citizens: contact the nearest U.S. embassy/consulate and the U.S. State Department at +1-202-501-4444 (from abroad). If a U.S. citizen is arrested or detained abroad →
Images
Visual references coming soon.
If it’s too intense
If an experience becomes overwhelming, the goal is to stay safe and let it pass — most difficult experiences ease as the drug wears off.
- Get to a calm, safe space with someone you trust who is sober and can stay with you.
- Cool down if you’re overheating — move somewhere cool, remove extra layers, rest. Overheating is especially a risk with stimulants and MDMA.
- Sip water to thirst — but don’t over-hydrate. Drinking large amounts of plain water (especially after MDMA) can dangerously dilute your blood sodium (hyponatremia). Electrolytes help more than volume.
- Slow your breathing — long, slow exhales help settle a racing heart and anxiety.
- A sugary drink, fruit juice, or a snack can ease shakiness and the anxiety that comes with low blood sugar.
- Do not take more, and do not add another substance to manage it. Redosing or adding something else (including a sedative like a benzodiazepine) can make things worse, not better.
With depressants, the danger is over-sedation: if someone is very drowsy, hard to wake, or breathing slowly, treat it as an emergency.
Source: general harm-reduction guidance from SAMHSA, NIH/NIDA, and MedlinePlus, in our own words. Draft — not yet medically reviewed.
Forensic dossier
Draft · every field is source-cited or marked “Unknown — pending review”Identity
- PubChem CID
- N/A — no single PubChem compound (mixture/class/plant/concept)
- IUPAC name
- N/A — no single PubChem compound (mixture/class/plant/concept)
- Molecular formula
- N/A — no single PubChem compound (mixture/class/plant/concept)
- SMILES
- N/A — no single PubChem compound (mixture/class/plant/concept)
- InChIKey
- N/A — no single PubChem compound (mixture/class/plant/concept)
- Synonyms / aliases
- fly agaric
Composition
- Composition
- Unknown — pending review (no single compound; needs an epidemiology / composition source)
Physical / pill characteristics
- Dosage form
- HUMAN OTC DRUGopenFDA drug label ↗ · retrieved 2026-06-18
- Shape
- Unknown — pending review (verify tablet imprint/shape against NLM Pillbox/DailyMed; N/A if not an oral tablet)
- Color
- Unknown — pending review (verify tablet imprint/shape against NLM Pillbox/DailyMed; N/A if not an oral tablet)
- Imprint
- Unknown — pending review (verify tablet imprint/shape against NLM Pillbox/DailyMed; N/A if not an oral tablet)
- Score
- Unknown — pending review (verify tablet imprint/shape against NLM Pillbox/DailyMed; N/A if not an oral tablet)
Scheduling & legal status
- US schedule
- Unknown — pending review
- International
- Unknown — pending review
Dosage
Pending medical reviewer
